SEGLUROMET 1000 mg/1

Segluromet 1000 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Segluromet 1000 mg/1 is primarily used to improve glycemic control in adults with type 2 diabetes. It works by helping the body respond better to insulin and reducing sugar absorption in the kidneys. This combination medication is often prescribed alongside diet and exercise for comprehensive diabetes management.

Common effects of Segluromet 1000 mg/1 may include symptoms like nausea, diarrhea, or headache. Some users might experience urinary tract infections or low blood sugar, especially when combined with other diabetes medications. Individual responses can vary, and not everyone will encounter these effects.

Segluromet 1000 mg/1 should be handled with care, particularly for those with kidney issues or a history of lactic acidosis. It's important to stay hydrated and monitor blood sugar levels regularly. Consult a healthcare provider before starting this medication, especially if you have other medical conditions or are taking other medications.

Segluromet 1000 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol can increase the risk of lactic acidosis, so it should be avoided. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.